Two cases of pregabalin neurotoxicity in chronic kidney disease patients

Affiliations

¹ Department of Internal Medicine, School of Medicine Gyeongsang National University, Jinju, South Korea.
² Department of Internal Medicine, School of Medicine Gyeongsang National University, Jinju, South Korea ; Institute of Health Science, School of Medicine Gyeongsang National University, Jinju, South Korea.

Dong-Won Lee et al. NDT Plus. 2011 Apr.

. 2011 Apr;4(2):138.

doi: 10.1093/ndtplus/sfq219.

¹ Department of Internal Medicine, School of Medicine Gyeongsang National University, Jinju, South Korea.
² Department of Internal Medicine, School of Medicine Gyeongsang National University, Jinju, South Korea ; Institute of Health Science, School of Medicine Gyeongsang National University, Jinju, South Korea.

No abstract available

References

1. Randinitis EJ, Posvar EL, Alvey CW, et al. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol. 2003;43:277–283. - PubMed
1. Yoo L, Matalon D, Hoffman RS, et al. Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure. Am J Kidney Dis. 2009;54:1127–1130. - PubMed
1. Homs M, Bonal J, Canas L, et al. Pregabalin toxicity in a chronic haemodialysis patient. Nefrologia. 2007;27:236. - PubMed
1. Healy DG, Ingle GT, Brown P. Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure. Mov Disord. 2009;24:2028–2029. - PubMed